Navigation Links
FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
Date:10/14/2011

SILVER SPRING, Md., Oct. 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Patients with thalassemia have excess iron in the body from the frequent blood transfusions (transfusional iron overload), a condition that is serious and can be fatal.  These patients also have a risk of developing liver disease, diabetes, arthritis, heart failure or an abnormal heart rhythm.  

The standard of care to treat transfusional iron overload is chelation therapy – chemical agents that are used to remove heavy metals from the body. Ferriprox is intended for use when chelation therapy is inadequate.

"Ferriprox represents the first new FDA-approved treatment for this disorder since 2005," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.

The safety and effectiveness of Ferriprox is based on an analysis of data from twelve clinical studies in 236 patients. Patients participating in the study did not respond to prior iron chelation therapy.  Ferriprox was considered a successful treatment for patients who experienced at least a 20 percent decrease in serum ferritin, a protein that stores iron in the body for later use. Half of the patients in the study experienced at least a 20 percent decrease in ferritin levels.

The most common side effects seen in patients who received Ferriprox included nausea, vomiting, abdominal and joint pain, urine discoloration (chromaturia), a decrease in the number of white blood cells (neutropenia), and an increase in
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Johnson & Johnson (NYSE: JNJ ... third party to review requests made to the Janssen ... for compassionate use of its investigational medicines. This new ... a single Janssen investigational medicine and, if successful, will ... across Johnson & Johnson. In keeping with ...
(Date:5/6/2015)... , May 6, 2015  Zimmer Holdings, Inc. (NYSE and ... that it will be presenting at the Bank of America ... hotel in Las Vegas, Nevada on ... A live webcast of the presentation can be accessed ... webcast will be archived for replay following the conference. ...
(Date:5/6/2015)... 6, 2015  The fairness of the proposed acquisition ... Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw ... for possible breaches of fiduciary duty and other violations ... for agreeing to sell the Company to Alexion.  On ... for Alexion to acquire GEVA in a transaction valued ...
Breaking Medicine Technology:Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 2Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 3Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 4Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 5WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2
... Radient Pharmaceuticals Corporation (OTCQX: RXPC.PK - News ... developer and marketer of cancer tests, today announces it ... in Taipei, Taiwan. Previously, Radient,s agreement with ... Radient,s flagship product Onko-Sure® cancer test in Taiwan.  Radient ...
... Dec. 21, 2011  Shareholders of Medco Health Solutions, Inc. (NYSE: ... Express Scripts. (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) ... vote present in person or by proxy at a special ... Merger dated July 20, 2011 by a margin of 99 ...
Cached Medicine Technology:Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 2Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 3Medco Shareholders Approve Merger With Express Scripts 2
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement ... Bizcard ™ platform. This exciting new SMS platform creates ... Sales / Services. Now you can reach out ... products, services and ticker symbol through an easy to ... LLC will provide managed support and services to advance ...
(Date:5/6/2015)... Sulphur Springs, Texas (PRWEB) May 06, 2015 ... the stages of the HIMSS EMR Adoption Model, ... remove paper, improve patient engagement and automate processes. ... had transitioned from paper-driven to electronic workflows, patient ... to hard copies of consents. With HIMSS Stage ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, ... in Florida while under the influence of Flakka, according to ... released by CBS4’s Peter D’Oench records Doby distraught in a ... around one year old. The drug treatment center in Florida ... named. The residents polled by CBS Miami express concern about ...
(Date:5/6/2015)... Va. (PRWEB) May 06, 2015 ... in the state of Virginia to acquire Intuitive ... surgical robot. The system upgrade includes enhanced surgical ... minimally invasive procedures across a wide spectrum of ... options, reduced pain and quicker recovery times. , ...
(Date:5/6/2015)... Baptist Medical Center Jacksonville and the ... Florida and southeast Georgia region offering MAKOplasty® Hip ... total hip replacement surgery performed using the RIO® ... enables the accurate alignment and positioning of implants. ... partial knee resurfacing using the RIO system since ...
Breaking Medicine News(10 mins):Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4
... researchers report 80 percent success with their method, , ... that they,ve developed ways to detect 80 percent of ... more than one in 10 women who give birth. ... would make it possible to intervene to prevent it ...
... FAIRFAX, Va.The Society of Interventional Radiology Foundation recently ... a future scholarship fund for interventional radiology fellows ... dedicated to advancing the clinical needs of interventional ... conducting pivotal basic and clinical trials research. ...
... 2009 Late-breaking data from SPIRIT IV, a large-scale ... shows that an everolimus-eluting stent demonstrated enhanced safety and ... artery lesions when compared to a paclitaxel-eluting stent, and ... drug-eluting stents without sacrificing safety. Unlike similar ...
... conducted by Dr. Eric Blough and his colleagues at ... pain reliever acetaminophen may help prevent age-associated muscle loss ... may affect the regulation of protein kinase B (Akt), ... regulation of cellular survival, proliferation and metabolism. The ...
... influenza could slow growth in key industries and stall already-weak ... says a health economist in the University of Alabama at ... vitally important sectors in the economy of many U.S. cities ... the spread of the virus, consumers and businesses may respond ...
... ... External services for pharmaceutical firms have shown consistent growth in recent ... The global share of biotechnology services spending is in the billions ... of high-quality external services available to pharma ranges from supportive IT, ...
Cached Medicine News:Health News:Predicting Postpartum Depression May Be Possible 2Health News:Society of Interventional Radiology Foundation receives $1 million legacy gift 2Health News:SPIRIT IV trial shows everolimus stent sets new standard for event-free survival 2Health News:Research shows safe dosages of common pain reliever may help prevent conditions related to aging 2Health News:Swine flu could wreak more havoc on US economy, says UAB economist 2Health News:Cambridge Healthtech Institute and Bio-IT World Launch a New eNewsletter: Pharma Services News 2
... duet Signature Series multipurpose gamma ... FDG imaging applications. The system uniquely combines ... the features and flexibility of modern day ... unit.,The e.cam duet maximizes camera ...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
... AXIOM Artis FA is ... C-arm system whose flexible ... for vascular and non-vascular ... provides complete ergonomic system ...
.60 x 22mm, angled 60, .33mm end port [Simcoe]...
Medicine Products: